hotspot -WSS

hotspot

author：explore 2025-09-30 00:34:48 - browse：57

In a surprise move, the Food and Drug Administration has called for a meeting of outside advisers to discuss whether an Alzheimer’s drug from Eli Lilly should be approved, even as many outsiders expected the medicine to receive regulatory clearance this month.

The drug, donanemab, succeeded in its Phase 3 trial, resulting in a 35% slowing of Alzheimer’s disease progression versus placebo. But Lilly on Friday said that the FDA expects to call a meeting of an advisory committee to review the trial, saying that the agency had told the company “it wants to further understand topics related to evaluating the safety and efficacy of donanemab, including the safety results in donanemab-treated patients and the efficacy implications of the unique trial design” of the study.

A date for the meeting has not been set yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Affordable Connectivity Program vital to health care, experts say

WSS

DeSantis talks Trump, trans issues and 'what wokeness is'

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Sweden knocks USA out of World Cup in penalty kicks

Kansas bar where gunfire wounded 9 last month closes permanently

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

It was time to plan for my old age. If only I could stop crying

leisure time

hotspot

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Trump used to be more articulate. What could explain the change?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

ChatGPT in medicine: STAT answers readers' burning questions

Failure, not just success, should guide future doctors

After affirmative action ruling, medical educators look to 'holistic review'

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Novavax promises a turnaround & Lilly roils the obesity market

Tesla recalling nearly 16,000 of its 2021

leisure time

Slovenia has suffered its worst

Divers poised to search for children washed away in Pennsylvania flash flood

Doctors are clamoring for more clarity on Paxlovid prescribing

NFL doctors' conflicts of interest could endanger players, report says

DeSantis talks Trump, trans issues and 'what wokeness is'

Failure, not just success, should guide future doctors

explore

hotspot

hotspot

focus